By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ionis Pharmaceuticals 

2855 Gazelle Court

Carlsbad  California  92010  U.S.A.
Phone: 760-931-9200 Fax: n/a


SEARCH JOBS

Ionis Pharmaceuticals, Inc., located in the North San Diego County city of Carlsbad, was founded in 1989 to create advanced, novel medicines to treat complex and challenging diseases. We are the pioneer in the discovery and development of antisense drugs with more than 1300 patents.

Ionis is a challenging, motivating and rewarding environment designed to foster innovation and scientific excellence. Our founding goals have changed little in over 27 years and our success is a direct result of our outstanding employees. We are interested in bringing together individuals with different skill sets into this creative environment to be part of a productive team. Join us and experience our unique culture while you develop and expand your career.

See Collaborations


Key Statistics


Email:
Ownership: Public

Web Site: Ionis Pharma
Employees: 400+
Symbol: IONS
 




Segment
Antisense





Company News
GlaxoSmithKline (GSK) Ditches Ionis Pharma (IONS)'s Inotersen and IONIS-FB-LRx 8/11/2017 7:10:11 AM
Ionis Pharma (IONS) Provides Improved 2017 Guidance Following Strong Financial Performance 8/8/2017 12:22:52 PM
Akcea Therapeutics And Ionis Pharma (IONS) Announce Submission Of Marketing Authorization Application For Volanesorsen To The EMA 7/27/2017 6:35:00 AM
Ionis Pharma (IONS) To Hold Second Quarter 2017 Financial Results Webcast 7/25/2017 11:36:43 AM
Ionis Pharma (IONS) Earns $10 Million Milestone Payment From Biogen (BIIB) For Advancing A New Program In Its Neurology Collaboration 7/17/2017 8:05:17 AM
Ionis Pharma (IONS) Release: New Data Presented At Peripheral Nerve Society Meeting Further Support Potential Benefit Of Inotersen 7/10/2017 8:14:18 AM
Ionis Pharma (IONS) Release: Enrollment In Phase I/IIa Study Of IONIS-HTT Rx In Patients With Huntington's Disease Completed And Open-Label Extension Study To Open In 2H 2017 6/22/2017 6:33:14 AM
Ionis Pharma (IONS) Release: SPINRAZA (Nusinersen) Approved In The European Union 6/1/2017 7:58:09 AM
Safety Concerns Raised as Ionis Pharma (IONS)'s Inotersen Meets Both Primary Endpoints in Late-Stage Study 5/15/2017 6:00:21 AM
Ionis Pharma (IONS) Provides Corporate Update At 2017 Annual Meeting Of Stockholders 5/11/2017 10:28:11 AM
12345678910...
//-->